Indian drugmaker Cipla's Q1 profit misses estimatesJul 22, 2026Cipla's Q1 profit fell 39.2% to 7.89 billion rupees, missing estimates due to muted generic cancer drug sales and supply disruptions affecting lanreotide in its U.S. business.Indian drugmaker Cipla's Q1 profit misses estimatesreutersTopic tracking2026-07-22Indian drugmaker Cipla's Q1 profit misses estimatesFAQWhat was Cipla's consolidated net profit for the quarter ended June 30, and how did it compare to analyst expectations?+What were the main reasons cited for Cipla's third consecutive quarterly profit decline in Q1?+
ChemBrief